Dallas, Texas–(Newsfile Corp. – November 16, 2020) – Puration, Inc. (OTC Pink: PURA) today announced the release of an interview of CEO, Brian Shibley conducted by CEO Roadshow in association with OTC PR Wire (www.otcprwire.com) – the #1 solution for press, financial disclosure and multimedia solutions for companies trading in the OTC Market.

In the interview, Mr. Shibley elaborates on the Company’s new hemp processing plant initiative being built on a recently acquired 72-acre property in Farmersville, Texas. The acquisition and the corresponding hemp processing plant initiative was announced last week. The announcement last week included details on the Company’s pharmaceutical and neurocritical extraction partnership with PAO Group, Inc. (OTC Pink: PAOG) and co-packing partnership with Alkame Holdings, Inc. (OTC Pink: ALKM) that are key components of PURA’s overall hemp processing plant initiative.

PURA CEO Roadshow Interview

[youtube https://www.youtube.com/watch?v=HUjcgkGg_PY]

Cannot view this video? Visit:
https://www.youtube.com/watch?v=HUjcgkGg_PY

Sign up to receive the latest updates at www.purationinc.com.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
[email protected]
(800) 861-1350

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68265